BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36179541)

  • 1. Utilisation of primary care electronic patient records for identification and targeted invitation of individuals to a lung cancer screening programme.
    Dickson JL; Hall H; Horst C; Tisi S; Verghese P; Worboys S; Perugia A; Rusius J; Mullin AM; Teague J; Farrelly L; Bowyer V; Gyertson K; Bojang F; Levermore C; Anastasiadis T; McCabe J; Devaraj A; Nair A; Navani N; Hackshaw A; Quaife SL; Janes SM;
    Lung Cancer; 2022 Nov; 173():94-100. PubMed ID: 36179541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing, updating and utilising primary care smoking records for lung cancer screening.
    McCutchan G; Engela-Volker J; Anyanwu P; Brain K; Abel N; Eccles S
    BMC Pulm Med; 2023 Nov; 23(1):445. PubMed ID: 37974137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmented meaningful use criteria to identify patients eligible for lung cancer screening.
    Raz DJ; Dunham R; Tiep B; Sandoval A; Grannis F; Rotter A; Kim JY
    Ann Thorac Surg; 2014 Sep; 98(3):996-1002. PubMed ID: 25063304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telephone risk-based eligibility assessment for low-dose CT lung cancer screening.
    Dickson JL; Hall H; Horst C; Tisi S; Verghese P; Mullin AM; Teague J; Farrelly L; Bowyer V; Gyertson K; Bojang F; Levermore C; Anastasiadis T; Sennett K; McCabe J; Devaraj A; Nair A; Navani N; Callister ME; Hackshaw A; ; Quaife SL; Janes SM
    Thorax; 2022 Oct; 77(10):1036-1040. PubMed ID: 35863766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized Electronic Promotion of Lung Cancer Screening: A Pilot.
    Begnaud AL; Joseph AM; Lindgren BR
    JCO Clin Cancer Inform; 2017 Nov; 1():1-6. PubMed ID: 30657381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What factors do patients consider most important in making lung cancer screening decisions? Findings from a demonstration project conducted in the Veterans Health Administration.
    Lillie SE; Fu SS; Fabbrini AE; Rice KL; Clothier B; Nelson DB; Doro EA; Moughrabieh MA; Partin MR
    Lung Cancer; 2017 Feb; 104():38-44. PubMed ID: 28212998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating Eligibility for Lung Cancer Screening by Neighborhood in Philadelphia Using Previous and Current USPSTF Guidelines.
    McIntire RK; Lewis E; Zeigler-Johnson C; Shusted C; Barta J; Juon HS; Keith SW; Klein G
    Popul Health Manag; 2022 Apr; 25(2):254-263. PubMed ID: 35442796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an Electronic Health Record-Based Algorithm for Predicting Lung Cancer Screening Eligibility in the Population-Based Research to Optimize the Screening Process Lung Research Consortium.
    Burnett-Hartman AN; Powers JD; Hixon BP; Carroll NM; Frankland TB; Honda SA; Saia C; Rendle KA; Greenlee RT; Neslund-Dudas C; Zheng Y; Vachani A; Ritzwoller DP
    JCO Clin Cancer Inform; 2023 Sep; 7():e2300063. PubMed ID: 37910824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Uptake Appropriateness of Computed Tomography for Lung Cancer Screening According to Patients Meeting Eligibility Criteria of the US Preventive Services Task Force.
    Liu Y; Pan IE; Tak HJ; Vlahos I; Volk R; Shih YT
    JAMA Netw Open; 2022 Nov; 5(11):e2243163. PubMed ID: 36409492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Lung Screen Uptake Trial (LSUT): protocol for a randomised controlled demonstration lung cancer screening pilot testing a targeted invitation strategy for high risk and 'hard-to-reach' patients.
    Quaife SL; Ruparel M; Beeken RJ; McEwen A; Isitt J; Nolan G; Sennett K; Baldwin DR; Duffy SW; Janes SM; Wardle J
    BMC Cancer; 2016 Apr; 16():281. PubMed ID: 27098676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for lung cancer: 2023 guideline update from the American Cancer Society.
    Wolf AMD; Oeffinger KC; Shih TY; Walter LC; Church TR; Fontham ETH; Elkin EB; Etzioni RD; Guerra CE; Perkins RB; Kondo KK; Kratzer TB; Manassaram-Baptiste D; Dahut WL; Smith RA
    CA Cancer J Clin; 2024; 74(1):50-81. PubMed ID: 37909877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New recommendation and coverage of low-dose computed tomography for lung cancer screening: uptake has increased but is still low.
    Li J; Chung S; Wei EK; Luft HS
    BMC Health Serv Res; 2018 Jul; 18(1):525. PubMed ID: 29976189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake of invitations to a lung health check offering low-dose CT lung cancer screening among an ethnically and socioeconomically diverse population at risk of lung cancer in the UK (SUMMIT): a prospective, longitudinal cohort study.
    Dickson JL; Hall H; Horst C; Tisi S; Verghese P; Mullin AM; Teague J; Farrelly L; Bowyer V; Gyertson K; Bojang F; Levermore C; Anastasiadis T; McCabe J; Navani N; Nair A; Devaraj A; Hackshaw A; Quaife SL; Janes SM;
    Lancet Public Health; 2023 Feb; 8(2):e130-e140. PubMed ID: 36709053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 10 Pillars of Lung Cancer Screening: Rationale and Logistics of a Lung Cancer Screening Program.
    Fintelmann FJ; Bernheim A; Digumarthy SR; Lennes IT; Kalra MK; Gilman MD; Sharma A; Flores EJ; Muse VV; Shepard JA
    Radiographics; 2015; 35(7):1893-908. PubMed ID: 26495797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invitation strategies and participation in a community-based lung cancer screening programme located in areas of high socioeconomic deprivation.
    Goodley P; Balata H; Alonso A; Brockelsby C; Conroy M; Cooper-Moss N; Craig C; Evison M; Hewitt K; Higgins C; Johnson W; Lyons J; Merchant Z; Rowlands A; Sharman A; Sinnott N; Sperrin M; Booton R; Crosbie PAJ
    Thorax; 2023 Dec; 79(1):58-67. PubMed ID: 37586744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers, Facilitators, and Suggested Interventions for Lung Cancer Screening Among a Rural Screening-Eligible Population.
    Schiffelbein JE; Carluzzo KL; Hasson RM; Alford-Teaster JA; Imset I; Onega T
    J Prim Care Community Health; 2020; 11():2150132720930544. PubMed ID: 32506999
    [No Abstract]   [Full Text] [Related]  

  • 17. Racial Disparities in Lung Cancer Screening: An Exploratory Investigation.
    Japuntich SJ; Krieger NH; Salvas AL; Carey MP
    J Natl Med Assoc; 2018 Oct; 110(5):424-427. PubMed ID: 30129479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial results of a lung cancer screening demonstration project: a local program evaluation.
    Fabbrini AE; Lillie SE; Partin MR; Fu SS; Clothier BA; Bangerter AK; Nelson DB; Doro EA; Bell BJ; Rice KL
    Am J Manag Care; 2018 Jun; 24(6):272-277. PubMed ID: 29939501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of lung cancer screening eligible population in the US and prediction of the eligibility with simplified criteria.
    Okon M; Williams J; Truong K; Yu Q; Griffin S; Zhang L
    Transl Cancer Res; 2024 May; 13(5):2155-2163. PubMed ID: 38881910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of Lung Cancer Screening Eligibility Using Simplified Criteria.
    Triplette M; Donovan LM; Crothers K; Madtes DK; Au DH
    Ann Am Thorac Soc; 2019 Oct; 16(10):1280-1285. PubMed ID: 31298946
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.